Mesenterial fibromatosis as the cause of an acute abdominal condition

Czech version

Authors: P. Kružliak ¹; D. Mištuna ²; K. Macháleková ³
Authors‘ workplace: Interné odd. NsP Zvolen, Vaše zdravie, n. o. ¹; Chirurgická klinika Jesseniovej lekárskej fakulty UK a Martinskej fakultnej nemocnice, Martin ²; Ústav patologickej anatómie Jesseniovej lekárskej fakulty UK a Martinskej fakultnej nemocnice, Martin ³
Published in: Gastroent Hepatol 2012; 66(4): 276-279
Category: Clinical and Experimental Gastroenterology: Case Report

Overview

Intra-abdominal fibromatosis is a locally aggressive though non-metastatic proliferation of fibrous tissue. It is a benign tumour which is mostly located on the abdominal wall, mesentery or in the retroperitoneal space. It is associated with Gardner’s syndrome or occurs sporadically. Intra-abdominal fibromatosis often leads to problems in the differential diagnosis of myofibroblastic and gastrointestinal stromal tumours, which are however characterized by much more aggressive biological behaviour and metastatic pattern. The authors described the case of an 82-year old man operated for diffuse peritonitis due to perforation of the small intestine based on mesenterial fibromatosis infiltrating the small intestine and the abdominal wall.

Key words:
mesenterial fibromatosis – Gardner’s syndrome – gastrointestinal stromal tumours (GISTs) – immunohistochemical investigation

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
20. 7. 2011

Accepted:
20. 9. 2011

Sources

1. Yannopoulos K, Stout AP. Primary solid tumours of the mesentery. Cancer 1963; 16: 914–927.

2. Yantiss RK, Spiro IJ, Compton C et al. Gastrointestinal stromal tumor versus Intraabdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. Am J Surg Pathol 2000; 24(7): 947–957.

3. Gardner EJ. Follow-up study of family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts. Am J Hum Genet 1962; 14: 376–390.

4. Burke A, Sobin LH, Shekitka KM. Intraabdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 1990; 14(4): 335–341.

5. Miettinen M, Monihan J, Sarlomo-Rikala M. Gastrointestinal stromal tumors, Smooth muscle tumors (GISTs) primary in the omentum and mesentery clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999; 23(9): 1109–1118.

6. Gurbuz AK, Giardello FM, Peterson GM et al. Desmoid tumours in familial adenomatous polyposis. GUT 1994; 35(3): 377–381.

7. Chen FJ, Jeng KS. Intraabdominal fibromatosis. A rare complication of previous abdominal surgery. J Surg 1999; 32: 97–100.

8. Lim CL, Walker MJ, Mehta RR et al. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 1986; 22(5): 583–587.

9. Gansar GF, Markowitz IP, Cerise EJ. Thirty years of experience with desmoid tumors at Charity Hospital. Am Surg 1987; 53(6): 318–319.

10. Smith AJ, Lewis JJ, Merchant NB et al. Surgical management of intraabdominal desmoid tumours. Br J Surg 2000; 87(5): 608–613.

11. Jalini L, Hemming D, Bhattacharaya V. Intraabdominal desmoid tumour presenting with perforation. Surgeon 2006; 4(2): 114–116.

12. Hailemariam S, Jaeger P, Goebel N. Mesenteric fibromatosis with ureteric stenosis. Postgrad Med J 1988; 64(747): 79–81.

13. Messiou C, Chalmers AG, Dexter S. An unusual case of ureteric obstruction. Br J Radiol 2005; 78(933): 848–850.

14. Tsamandas AC, Tzanakakis GN, Karatzas T et al. Mesenteric fibromatosis. Br J Clin Pract 1994; 48(2): 79–81.

15. Casillas J, Sais GJ, Greve JL et al. Imaging of intra- and extraabdominal desmoid tumours. Radiographics 1991; 11(6): 959–968.

16. Monihan JM, Carr NJ, Sobin LH. CD34 immunoexpresion in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology 1994; 25(5): 469–473.

17. Sarlomo-Rikala M, Kovatich A, Barusevicius A et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998; 11(8): 728–734.

18. Miettine M, Lasota J. Gastrointestinal stromal tumors-definition, chemical, histological, Immuno-histochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438(1): 1–12.

19. Montgomery E, Torbenson MS, Kaushal M et al. Beta-catenin Immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 2002; 26(10): 1296–1301.

20. Nuyttens JJ, Rust PF, Thomas CR Jr. et al. Surgery versus radiation therapy for patients with aggresive fibromatosis or desmoid tumors. A comparative review of 22 articles. Cancer 2000; 88(7): 1517–1523.

21. Janinis J, Patriki M, Vini L et al. The pharmacological treatment of aggresive fibromatosis: a systematic review. Ann Oncol 2003; 14(2): 181–190.